Read More

Silvaco Analysts Recommend The Stock As Unique Small-Cap Opportunity In Semiconductor Design

Silvaco initiated with Buy rating and $26 price target by Rosenblatt analyst, well-positioned to benefit from EDA market with strong TCAD position and growth opportunities. Needham analyst also gives Buy rating and $28 target, forecasts improved margins and revenue.

CDNS

Read More

What’s Going On With SoFi Technologies Stock?

SoFi announced that chief legal officer Rob Lavet will retire from the company and be replaced by Simcock, who previously served as vice chairman of JPMorgan Chase's legal department and as general counsel of Chase's retail businesses. Simcock will oversee legal affairs, regulatory compliance and corporate governance at SoFi.

JPM

Read More

Johnson & Johnson’s Late-Breaking Results From Its PALOMA-2 Study Of Subcutaneous Amivantamab In Combination With Lazertinib Show Clinically Meaningful Antitumor Response And Improved Safety Profile In Patients With EGFR-Mutated Non-Small Cell Lung Can…

administration in new Phase 2 dataCHICAGO, June 3, 2024 /PRNewswire/ -- Johnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as

JNJ